Abraxane: Breast And Lung Cancer Drug Almost Improves Pancreatic Cancer Survival
Category: WELLNESS
Patients with advanced forms of pancreatic cancer, such as those tested in the Celgene trial, typically live 5.6 to 6.8 months
By Reuters, Reuters, 2012-11-10